The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Barrett Esophagus and Risk of Esophageal Cancer: A Clinical Review
Abstract
IMPORTANCE: Barrett esophagus, a complication of gastroesophageal reflux disease (GERD), predisposes patients to esophageal adenocarcinoma, a tumor that has increased in incidence more than 7-fold over the past several decades. Controversy exists regarding the issues of endoscopic screening and surveillance for Barrett esophagus, treatment for the underlying GERD, and the role of endoscopic eradication therapy. OBJECTIVES: To review current concepts on the pathogenesis, diagnosis, and treatment of Barrett esophagus; to discuss the importance of dysplasia and the role of endoscopic eradication therapy for its treatment; and to review current management guidelines. EVIDENCE REVIEW: MEDLINE and the Cochrane Library were searched from 1984 to April 2013. Additional citations were obtained by reviewing references from selected research and review articles. FINDINGS: Risk factors for cancer in Barrett esophagus include chronic GERD, hiatal hernia, advanced age, male sex, white race, cigarette smoking, and obesity with an intra-abdominal body fat distribution. The annual risk of esophageal cancer is approximately 0.25% for patients without dysplasia and 6% for patients with high-grade dysplasia. High-quality studies have found no significant differences in cancer incidence for patients with Barrett esophagus whose GERD is treated medically or surgically. Endoscopic eradication therapy with radiofrequency ablation significantly reduces the frequency of progression to cancer for patients with high-grade dysplasia. CONCLUSIONS AND RELEVANCE: Endoscopic screening is recommended for patients with multiple risk factors for cancer in Barrett esophagus. For patients with Barrett esophagus without dysplasia, endoscopic surveillance at intervals of 3 to 5 years is recommended, and GERD is treated much as it is for patients without Barrett esophagus. Endoscopic eradication therapy is the treatment of choice for high-grade dysplasia and is an option for low-grade dysplasia. Endoscopic eradication therapy is not recommended for the general population of patients with nondysplastic Barrett esophagus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
Wang, K. K., & Sampliner, R. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01835.x · Cited by 2,014
Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease
Katz, P. O., Gerson, L. B., & Vela, M. F. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.444 · Cited by 1,767
Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
Shaheen, N. J., Sharma, P., Overholt, B. F., Wolfsen, H. C., Sampliner, R. E., Wang, K. K., Galanko, J. A., Bronner, M. P., Goldblum, J. R., Bennett, A. E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808145 · Cited by 1,438
Self-citationIncidence of Adenocarcinoma among Patients with Barrett's Esophagus
Hvid-Jensen, F., Pedersen, L., Drewes, A. M., Sørensen, H. T., & Funch-Jensen, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103042 · Cited by 1,371
American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
Spechler, S. J., Sharma, P., Souza, R. F., Inadomi, J. M., & Shaheen, N. J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.031 · Cited by 1,060
Self-citation(2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.030 · Cited by 1,009
Prevalence of Barrett’s Esophagus in the General Population: An Endoscopic Study
Ronkainen, J., Aro, P., Storskrubb, T., Johansson, S., Lind, T., Bolling–Sternevald, E., Vieth, M., Stolte, M., Talley, N. J., & Agréus, L. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.08.053 · Cited by 940
Spechler, S. J., Lee, E., Ahnen, D., Goyal, R. K., Hirano, I., Ramirez, F., Raufman, J.-P., Sampliner, R., Schnell, T., Sontag, S., et al. (2001) · JAMA · doi:10.1001/jama.285.18.2331 · Cited by 909
Self-citationPractice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus
Sampliner, R. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00243-3 · Cited by 817
Is there publication bias in the reporting of cancer risk in Barrett's esophagus?
Shaheen, N. J., Crosby, M. A., Bozymski, E. M., & Sandler, R. S. (2000) · Gastroenterology · doi:10.1053/gast.2000.9302 · Cited by 758
Bhat, S., Coleman, H. G., Yousef, F., Johnston, B. T., McManus, D. T., Gavin, A. T., & Murray, L. J. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr203 · Cited by 741
Pech, O., Behrens, A., May, A., Nachbar, L., Gossner, L., Rabenstein, T., Manner, H., Guenter, E., Huijsmans, J., Vieth, M., et al. (2008) · Gut · doi:10.1136/gut.2007.142539 · Cited by 678
Our new president—Jon I. Isenberg, M.D
Boland, C. R., & Yamada, T. (2001) · Gastroenterology · doi:10.1053/gast.2001.24057 · Cited by 629
The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis
Desai, T. K., Krishnan, K., Samala, N., Singh, J., Cluley, J., Perla, S., & Howden, C. W. (2012) · Gut · doi:10.1136/gutjnl-2011-300730 · Cited by 609
Prevalence of metaplasia at the gastro-oesophageal junction
Spechler, S. J., Zeroogian, J. M., Antonioli, D. A., Wang, H. H., & Goyal, R. K. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90349-2 · Cited by 564
Self-citationClostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis
Janarthanan, S., Ditah, I., Adler, D. G., & Ehrinpreis, M. N. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.179 · Cited by 538
Corley, D. A., Kerlikowske, K., Verma, R., & Buffler, P. (2003) · Gastroenterology · doi:10.1053/gast.2003.50008 · Cited by 527
Surveillance and survival in Barrett's adenocarcinomas: A population-based study
Corley, D. A., Levin, T. R., Habel, L. A., Weiss, N. S., & Buffler, P. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.31879 · Cited by 506
Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn
Rex, D. K., Cummings, O. W., Shaw, M., Cumings, M. D., Wong, R. K. H., Vasudeva, R. S., Dunne, D., Rahmani, E. Y., & Helper, D. J. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.030 · Cited by 504
Quante, M., Bhagat, G., Abrams, J. A., Marache, F., Good, P., Lee, M., Lee, Y., Friedman, R. A., Asfaha, S., Dubeykovskaya, Z. A., et al. (2012) · Cancer Cell · doi:10.1016/j.ccell.2026.07.005 · Cited by 486
Bavishi, C., & DuPont, H. L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04874.x · Cited by 480
Low-Grade Dysplasia in Barrett's Esophagus: Overdiagnosed and Underestimated
Curvers, W. L., ten Kate, F. J., Krishnadath, K. K., Visser, M., Elzer, B., Baak, L. C., Bohmer, C., Mallant-Hent, R. C., van Oijen, A., Naber, A. H., et al. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.171 · Cited by 463
Ricketts, R. R. (1998) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(98)90392-x · Cited by 452
The incidence of Helicobacter pylori infection.
Parsonnet, J. (1995) · PubMed · Cited by 438
Time Trends of Gastroesophageal Reflux Disease: A Systematic Review
El–Serag, H. B. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.016 · Cited by 432
Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak?
Pohl, H., Sirovich, B., & Welch, H. G. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0012 · Cited by 421
Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression
Ouatu–Lascar, R., Fitzgerald, R. C., & Triadafilopoulos, G. (1999) · Gastroenterology · doi:10.1053/gast.1999.0029900327 · Cited by 377
Screening and Surveillance for Barrett Esophagus in High-Risk Groups: A CostUtility Analysis
Inadomi, J. M., Sampliner, R., Lagergren, J., Lieberman, D., Fendrick, A. M., & Vakil, N. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00009 · Cited by 361
Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk
Provenzale, D. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00332-9 · Cited by 357
The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus
Evans, J. A., Early, D. S., Fukami, N., Ben-Menachem, T., Chandrasekhara, V., Chathadi, K. V., Decker, G. A., Fanelli, R. D., Fisher, D. A., Foley, K. Q., et al. (2012) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2012.08.004 · Cited by 354
Buttar, N. S., Wang, K. K., Leontovich, O., Westcott, J. Y., Pacifico, R. J., Anderson, M. A., Krishnadath, K. K., Lutzke, L. S., & Burgart, L. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32371 · Cited by 348
Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: A systematic review
Dulai, G. S., Guha, S., Kahn, K. L., Gornbein, J., & Weinstein, W. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.30297 · Cited by 345
Residual Embryonic Cells as Precursors of a Barrett's-like Metaplasia
Wang, X., Ouyang, H., Yamamoto, Y., Kumar, P. A., Wei, T. S., Dagher, R., Vincent, M., Lu, X., Bellizzi, A. M., Ho, K. Y., et al. (2011) · Cell · doi:10.1016/j.cell.2011.05.026 · Cited by 333
Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus
El-Serag, H. B., Aguirre, T. V., Davis, S., Kuebeler, M., Bhattacharyya, A., & Sampliner, R. E. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30228.x · Cited by 331
Kedika, R. R., Souza, R. F., & Spechler, S. J. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0951-9 · Cited by 324
Self-citationLong-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritis
Lamberts, R., Creutzfeldt, W., Strüber, H. G., Brunner, G., & Solcia, E. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90344-c · Cited by 323
Sharma, P. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00205-6 · Cited by 316
Souza, R. F., Shewmake, K., Beer, D. G., Cryer, B., & Spechler, S. J. (2000) · PubMed · Cited by 315
Self-citationYe, W., Chow, W.-H., Lagergren, J., Yin, L., & Nyrén, O. (2001) · Gastroenterology · doi:10.1053/gast.2001.29569 · Cited by 267
Leers, J. M., DeMeester, S. R., Oezcelik, A., Klipfel, N., Ayazi, S., Abate, E., Zehetner, J., Lipham, J. C., Chan, L., Hagen, J. A., et al. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e3181fbad42 · Cited by 251
Dunbar, K. B., & Spechler, S. J. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.78 · Cited by 240
Self-citationWani, S., Falk, G., Hall, M., Gaddam, S., Wang, A., Gupta, N., Singh, M., Singh, V., Chuang, K., Boolchand, V., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.11.008 · Cited by 235
Review article: proton pump inhibitors and bacterial overgrowth
WILLIAMS, C., & McCOLL, K. E. L. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02707.x · Cited by 221
Theisen, J., Nehra, D., Citron, D., Johansson, J., Hagen, J. A., Crookes, P. F., DeMeester, S. R., Bremner, C. G., DeMeester, T. R., & Peters, J. H. (2000) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(00)80032-3 · Cited by 217
Gastroesophageal Reflux Disease Treatment: Side Effects and Complications of Fundoplication
Richter, J. E. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.006 · Cited by 208
Kastelein, F., Spaander, M. C. W., Steyerberg, E. W., Biermann, K., Valkhoff, V. E., Kuipers, E. J., & Bruno, M. J. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.11.014 · Cited by 203
Proton‐pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus
Hillman, L. C., Chiragakis, L., Kaye, G. L., Clarke, A. C., & Shadbolt, B. (2004) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb05991.x · Cited by 195
Iijima, K., Henry, E., Moriya, A., Wirz, A., Kelman, A. W., & McColl, K. E. L. (2002) · Gastroenterology · doi:10.1053/gast.2002.32963 · Cited by 193
Cook, M. B., Shaheen, N. J., Anderson, L. A., Giffen, C., Chow, W., Vaughan, T. L., Whiteman, D. C., & Corley, D. A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.049 · Cited by 173
Sikkema, M., Looman, C. W. N., Steyerberg, E. W., Kerkhof, M., Kastelein, F., van Dekken, H., van Vuuren, A. J., Bode, W. A., van der Valk, H., Ouwendijk, R. J. T., et al. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.153 · Cited by 173
Influence of obesity on the risk of esophageal disorders
Lagergren, J. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.73 · Cited by 168
Systematic review: proton pump inhibitor‐associated acute interstitial nephritis
SIERRA, F., SUAREZ, M., REY, M., & VELA, M. F. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03407.x · Cited by 160
Sarosi, G., Brown, G., Jaiswal, K., Feagins, L. A., Lee, E., Crook, T. W., Souza, R. F., Zou, Y. S., Shay, J. W., & Spechler, S. J. (2008) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2007.00744.x · Cited by 160
Self-citationGastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor
Haigh, C. R., Attwood, S. E., Thompson, D. G., Jankowski, J. A., Kirton, C. M., Pritchard, D. M., Varró, A., & Dimaline, R. (2003) · Gastroenterology · doi:10.1053/gast.2003.50091 · Cited by 154
El‐Serag, H. B., Hashmi, A., Garcia, J. M., Richardson, P., Alsarraj, A., Fitzgerald, S. J., Vela, M. F., Shaib, Y. H., Abraham, N. S., Velez, M. E., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304189 · Cited by 152
Deshpande, A., Pasupuleti, V., Thota, P., Pant, C., Mapara, S. M., Hassan, S., Rolston, D. D. K., Sferra, T. J., & Hernández, A. V. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12065 · Cited by 152
Fraser, L.-A., Leslie, W. D., Targownik, L. E., Παπαϊωάννου, Α., & Adachi, J. D. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2112-9 · Cited by 145
Keszthelyi, D., Jansen, S. V., Schouten, G. A., de Kort, S., Scholtes, B., Engels, L. G. J. B., & Masclee, A. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04453.x · Cited by 142
Huo, X., Juergens, S., Zhang, X., Rezaei, D., Yu, C., Strauch, E. D., Wang, J., Cheng, E., Meyer, F. P., Wang, D. H., et al. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00092.2011 · Cited by 140
Self-citationKastelein, F., Spaander, M. C. W., Biermann, K., Steyerberg, E. W., Kuipers, E. J., & Bruno, M. J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.036 · Cited by 135
Zhou, C., Tsai, T.-H., Lee, H., Kirtane, T. S., Figueiredo, M., Tao, Y. K. K., Ahsen, O. O., Adler, D. C., Schmitt, J. M., Huang, Q. M., et al. (2012) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2012.02.003 · Cited by 123
Association Between Proton Pump Inhibitor Use and Anemia: A Retrospective Cohort Study
Sarzynski, E. M., Puttarajappa, C. M., Xie, Y., Grover, M., & Laird-Fick, H. S. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1589-y · Cited by 120
Zhu, H., Hart, C. A., Sales, D., et al. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46611-0 · Cited by 120
Merwat, S. N., & Spechler, S. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.87 · Cited by 109
Self-citationIncreasing incidence of Barrett’s oesophagus: a population-based study
Coleman, H. G., Bhat, S. K., Murray, L., et al. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9596-z · Cited by 107
Zhang, H. Y., Hormi-Carver, K. K., Zhang, X., Spechler, S. J., & Souza, R. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2518 · Cited by 106
Self-citationJohnson, D. A., & Oldfield, E. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.11.031 · Cited by 103
Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans
Rubenstein, J. H., Sonnenberg, A., Davis, J., McMahon, L. F., & Inadomi, J. M. (2008) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2008.02.062 · Cited by 94
The Association Between Barrett’s Esophagus and Helicobacter pylori Infection: A Meta‐Analysis
Fischbach, L. A., Nordenstedt, H., Kramer, J. R., Gandhi, S., Dick‐Onuoha, S., Lewis, A. B., & El‐Serag, H. B. (2012) · Helicobacter · doi:10.1111/j.1523-5378.2011.00931.x · Cited by 92
Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach
Souza, R. F., & Spechler, S. J. (2005) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.6.334 · Cited by 89
Self-citationCost-Effectiveness of Aspirin Chemoprevention for Barrett's Esophagus
Hur, C., Nishioka, N. S., & Gazelle, G. S. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh039 · Cited by 81
Proton pump inhibitor therapy predisposes to community‐acquired S treptococcus pneumoniae pneumonia
de Jager, C. P. C., Wever, P. C., Gemen, E. F. A., van Oijen, M. G. H., van Gageldonk‐Lafeber, A. B., Siersema, P. D., Kusters, G. C. M., & Laheij, R. J. F. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12069 · Cited by 78
Health-Related Quality of Life in Patients With Barrett's Esophagus: A Systematic Review
Crockett, S. D., Lippmann, Q. K., Dellon, E. S., & Shaheen, N. J. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.02.024 · Cited by 64
Barrett's metaplasia as a paradigm for understanding the development of cancer
Burke, Z. D., & Tosh, D. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.08.001 · Cited by 51
Role of Bacterial Overgrowth in the Stomach as an Additional Risk Factor for Gastritis
Naylor, G., & Axon, A. T. R. (2003) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2003/350347 · Cited by 39
Risk factors and chemoprevention in Barrett's esophagus – an update
Winberg, H., Lindblad, M., Lagergren, J., & Dahlstrand, H. M. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.667145 · Cited by 26
Recurrent Hypomagnesemia With Proton-Pump Inhibitor Rechallenge
Quasdorff, M., Mertens, J., Dinter, J., & Steffen, H. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-6-201109200-00022 · Cited by 26
Proton Pump Inhibitors and Helicobacter pylori Gastritis: Friends or Foes?
Kuipers, E. J. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_478.x · Cited by 14
Multi-Modality Therapy for Cancer of the Esophagus and GE Junction
Tejani, M. A., & Burtness, B. A. (2012) · Current Treatment Options in Oncology · doi:10.1007/s11864-012-0193-5 · Cited by 10
Cited by
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus
Shaheen, N. J., Falk, G. W., Iyer, P. G., & Gerson, L. B. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.322 · Cited by 1,501
Pyroptosis: A new frontier in cancer
Fang, Y., Tian, S., Pan, Y., Li, W., Wang, Q., Tang, Y., Yu, T., Wu, X., Shi, Y., Ma, P., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109595 · Cited by 1,049
Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities
Napier, K. J. (2014) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v6.i5.112 · Cited by 796
Global patterns in excess body weight and the associated cancer burden
Sung, H., Siegel, R. L., Torre, L. A., Pearson‐Stuttard, J., Islami, F., Fedewa, S. A., Goding Sauer, A., Shuval, K., Gapstur, S. M., Jacobs, E. J., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21499 · Cited by 548
Metadata
- Authors
- Spechler, S. J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2013-08-14
- Volume
- 310
- Issue
- 6
- Pages
- 627
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2144409354
- Cited by
- 284
- References
- 79
- FWCI
- 30.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.